The software also detected the ‘sequence effect’ in both iRBD and Parkinson’s patients—a progressive decline in movement speed and amplitude during repetitive actions. This effect could serve as an ...
Medtronic (NYSE: MDT) today announced study results backing its adaptive DBS algorithm for personalized therapy in Parkinson's.
(HealthDay News) — Machine learning and deep learning models applied to integrated clinical and claims data can improve prediction of chronic kidney disease (CKD) progression to end-stage renal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback